OraBio, Inc.

OraBio, Inc. is a dental health company specializing in innovative oral health solutions that address systemic health concerns. The company's flagship product is Periovance Dry Mouth Gel, an FDA-cleared medical device designed to treat xerostomia (dry mouth). Periovance features a natural enzyme formula that replicates saliva function and provides up to six hours of relief from dryness. The product is formulated to prevent dental decay, reduce disease progression, and support long-term oral wellness. OraBio positions its solution at the intersection of medical and dental practice, targeting patients with xerostomia caused by medications (antihistamines, decongestants, antihypertensives, antidepressants), systemic diseases (Sjögren's Syndrome, diabetes, autoimmune disorders), or cancer therapies including head and neck radiation. The company partners with dental DSOs, dental groups, and medical professionals including TAG, ADA, Elevate Dental, Dental Partners, AADH, Dental Care Alliance, Guardian Dentistry Partners, North American Dental Group, and Park Dental. OraBio emphasizes the clinical validation of its periodontal products and maintains FDA-approved, breakthrough technology positioning. The company serves both medical and dental professionals seeking to address the underdiagnosed and undertreated condition of dry mouth, which can lead to rampant decay, gingivitis, periodontitis, mucosal irritation, and systemic complications when left unaddressed.